Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation

Launched by CAIRO UNIVERSITY · Apr 10, 2008

Keywords

ClinConnect Summary

Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation A Double-Blind, Placebo-Controlled, Fixed-Dose, Randomized controlled Study

Introduction

From an epidemiological perspective, premature ejaculation (PE) has been reported as the most common male sexual dysfunction with overall prevalence rates estimated at around 30% .(Laumann et al., 1999).

PE is defined by the Diagnostic and Statistical Manual of Mental Disorders(revision IV) (DSM-IV-TR) as 'the persistent or recurrent ejaculation with minimal stimulation before, on, or shortly after penetration and before th...

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • One hundred married patients seek medical help for what they consider premature ejaculation with possible sexual intercourse equal or greater than 1 per week.
• Exclusion Criteria:
• • Erectile dysfunction accounting to Arabic version of IIEF(International Index of Erectile Dysfunction)
• • Chronic psychiatric or physical illness.
• • Alcohol or substance abuse.
• • Use of psychotropic and antidepressant medication.
• • Patient with prostatitis
• • Organic illness causing limitation of SSRI use.